Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The molecular biology and clinical features of amyloid neuropathy.

Muscle & nerve - 1 Oct 2007

Benson Merrill D, Kincaid John C

Abstract excerpt

Neuropathy is often a major manifestation of systemic amyloidosis. It is most frequently seen in patients with hereditary transthyretin (TTR) amyloidosis, but is also present in 20% of patients with systemic immunoglobulin light chain (primary) amyloidosis. Familial amyloid polyneuropathy (FAP) is the most common form of inherited amyloidotic polyneuropathy, with clinical and electrophysiologic findings similar...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies
Share to Apolipoprotein A-I
Share to Gelsolin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to TTR gene

Share to Molecular Biology

Share to Mutation

Share to Peripheral Nerves

Share to Prealbumin

Source

Identifiers

PMID: 17554795
DOI: 10.1002/mus.20821

Genes

FAP
TTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The molecular biology and clinical features of amyloid neuropathy.PMID 17554795Read ↗

Familial amyloidotic polyneuropathy and transthyretin.Semantic proximity Read ↗

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathySemantic proximity Read ↗

Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies.Semantic proximity Read ↗

Updates on hereditary transthyretin amyloidosis polyneuropathy.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathySemantic proximity Read ↗

Guideline of transthyretin-related hereditary amyloidosis for cliniciansSemantic proximity Read ↗

Neuropathy Associated with Systemic Amyloidosis.Semantic proximity Read ↗

[Hereditary transthyretin amyloidosis].Semantic proximity Read ↗

Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy ManagementSemantic proximity Read ↗

[Transthyretin-related hereditary amyloidosis].Semantic proximity Read ↗

The transthyretin amyloidoses: advances in therapySemantic proximity Read ↗

Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatmentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.